Skip to nav Skip to content

TAMPA, Fla. — The American Society for Radiation Oncology (ASTRO), the world’s largest society for radiation oncology professionals, has named its 2022 class of Fellows. Moffitt faculty members Thomas Dilling, M.D., and Eduardo Moros, Ph.D., are among the 27 recipients who will be awarded the designation during a special ceremony in October at ASTRO’s 64th Annual Meeting.

Dilling, a physician and senior member of Moffitt’s Radiation Oncology Department, provides radiotherapeutic treatment for patients with lung cancer. He is also a researcher focusing on how artificial intelligence can help generate novel insights into patient treatment and toxicity. He has assembled one of the largest and most complex databases of lung radiotherapy data in the world.

Moros, a medical physicist, is also a senior member of the Radiation Oncology Department. His career has focused on developing mathematical models, devices, techniques and systems to advance radiation oncology. He is working on advancing adaptive (personalized) radiation therapy using quantitative imaging analysis (radiomics) and artificial intelligence (machine learning) to gain biological/functional information from daily medical images.

Drs. Dilling and Moros are part of an elite group of physicians and medical physicists who are being recognized this year for their far-reaching contributions to the field of radiation oncology and their progress in advancing cancer research, education and patient care,” said Laura A. Dawson, M.D., FASTRO, chair of the ASTRO Board of Directors.

Awarded annually since 2006, the ASTRO Fellows program recognizes individuals who have made significant contributions to radiation oncology through research, education, patient care and/or service to the field. Since its inception, the designation has been awarded to just 421 of ASTRO’s 10,000 members worldwide.

More information about the Fellows program is available via the ASTRO website, including the complete list of ASTRO Fellows and information about the nomination and selection process.

About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 53 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 7,800 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter, Instagram and YouTube